Wednesday, June 10, 2020 4:06:08 PM
And perhaps the big volume is in anticipation of a good Q despite the negatives that might be contained in it.
I sure would like to see it acting more like Valens.
MediPharm Labs Corp., will file its first quarter 2020 financial statements and management's discussion and analysis for the three-month period ended March 31, 2020 ("First Quarter Financial Information") on or before June 29, 2020.
In response to the coronavirus pandemic, Canadian securities regulatory authorities have granted a blanket exemption allowing issuers an additional 45 days to complete their regulatory filings. Normally, MediPharm Labs would report first quarter results on or before May 15, 2020 but given the unprecedented disruptions caused by COVID-19, the Company is relying on this exemptive relief from the filing timelines for its First Quarter Financial Information required by sections 4.4 and 5.1(2) of National Instrument 51-102. In accordance with the blanket exemption, the Company is not permitted to file any preliminary or final prospectus while it is relying on this filing deadline relief.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM